Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
45 Leser
Artikel bewerten:
(0)

Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019 with Fisher & Paykel Healthcare, Philips Healthcare & ResMed Dominating

DUBLIN, Apr. 15, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/fmhk4s/global_sleep) has announced the addition of the "Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019" report to their offering.

600769

The Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 8.16 percent over the period 2014-2019.

Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. OSA is the common type of sleep apnea, and it causes snoring, when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Sleep apnea symptoms includes morning headaches, waking up frequently to urinate, and dry mouth and sore in the morning. Sleep apnea diagnostic devices such PSG, actigraphy systems, and pulse oximeters are used for the screening of sleep apnea, while positive airway pressure and oral appliances are used for sleep apnea therapy.

High adoption of home diagnostics for diagnosis of sleep apnea is a key trend ibn this market. Home diagnostics are convenient and cost-effective when compared to in-lab sleep tests and therefore are expected to propel the market growth.

According to the report, high prevalence of sleep apnea disorder in people worldwide is a major driver in the market. The disorder is common in both adults and children and can result in hypertension, stroke, type II diabetes or adult onset diabetes, weight gain, impotence and cardiovascular diseases.

Further, the report states that lack of patient compliance is a key challenges in the market. Discomfort coupled with nosebleeds, anxiety, appliance leaking, claustrophobia and nasal stuffiness contribute to non-compliance when using CPAP or BiPAP devices.

Key Vendors

  • Fisher & Paykel Healthcare
  • Philips Healthcare
  • ResMed

Other Prominent Vendors

  • Apnex Medical
  • Briggs Healthcare
  • Bunnell
  • Cadwell Laboratories
  • Carefusion
  • Clement Clarke International
  • Cleveland Medical Devices
  • Compumedics
  • Dehaier Medical Systems
  • DeVilbiss Healthcare
  • Drager Medical
  • Embla Systems
  • GE Healthcare
  • Hamilton Medical
  • ImThera Medical
  • Invacare Corporation
  • Itamar Medical
  • Natus Medical
  • Nihon Kohden
  • Salter Labs
  • Teleflex Medical
  • Ventus Medical
  • Weinmann Gerate fur Medizin
  • Zephyr Sleep Technologies

Key Topics Covered:

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Types of Sleep Apnea
  7. Disease Linked with the Sleep Apnea
  8. Symptoms Associated with Sleep Apnea
  9. Market Landscape
  10. Global Sleep Apnea Diagnostic and Therapeutic Devices Market
  11. Geographical Segmentation
  12. Buying Criteria
  13. Market Growth Drivers
  14. Drivers and their Impact
  15. Market Challenges
  16. Impact of Drivers and Challenges
  17. Market Trends
  18. Trends and their Impact
  19. Vendor Landscape
  20. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/fmhk4s/global_sleep

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.